FDA Regulatory Due Diligence in Mergers and Acquisitions for Medical Device Companies

;
Access Webinar Here

Related Events
Join Mailing List

Whether your company is acquiring other device companies, or itself may be acquired, it is critical to understand the process and best practices for FDA regulatory due diligence. The presenters have counseled companies on numerous transactions involving medical devices, including conducting FDA regulatory due diligence for firms contemplating making an acquisition, as well as preparing acquisition targets for the types of diligence inquiries they may receive and how to respond. We will cover:

  • Best practices and avoiding pitfalls when conducting FDA regulatory due diligence
  • How to craft effective “reps and warranties”
  • Integration and managing post-acquisition risks

Covington & Burling LLP Presenters
Pamela F. Forrest
Partner

Scott D. Danzis
Partner

Targeted Audiences

  • Regulatory Affairs
  • Due Diligence
  • Compliance

Industries Represented

  • Medical Device

Contact:

Brooke Akins | Division Director, Life Science Programs
312.224.1693 | webinars@q1productions.com